Staff

Drug Discovery and Precision Medicine Focus Of Google Cloud’s AI-powered Solutions

Drug Discovery and Precision Medicine Focus Of Google Cloud’s AI-powered Solutions

Google Cloud recently announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and … Read more

Sherlock Biosciences To Bring SynBio Into Homes

Sherlock Biosciences To Bring SynBio Into Homes

It is inspiring to see evidence that the pace of innovation is narrowing the time between scientific curiosity and engineered scaling, leading to potential real world impacts within just a few years. One example is Sherlock Biosceinces. Its CRISPR-based SHERLOCK™ and synthetic biology-based INSPECTR™ will bring together the accuracy of PCR with the convenience and … Read more

Immunotherapy: The Making Of A Revolution

Immunotherapy: The Making Of A Revolution

To learn how something works is to understand how it’s built. How it came to be. That’s true not only if you play a guitar or repair motorcycle engines, but also if you study the biological systems that make life possible. Evolutionary studies, comparing the development of these systems across animals and organisms, are now … Read more

Pfizer Will Collaborate With Beam Therapeutics For In Vivo Base Editing

Pfizer Will Collaborate With Beam Therapeutics For In Vivo Base Editing

Today, Pfizer Inc. and Beam Therapeutics Inc., a biotechnology company developing precision genetic medicines through base editing, announced an exclusive four-year research collaboration focused on in vivo base editing programs for three targets for rare genetic diseases of the liver, muscle and central nervous system. Investors should note Pfizer will pay Beam $300 million up … Read more

Mayo Clinic Reports mRNA Progress In Cancer Treatment

Mayo Clinic Reports mRNA Progress In Cancer Treatment

Mayo Clinic research shows treatment improvement by adding messenger RNA, or mRNA therapy improves the response to cancer immunotherapy in patients who weren’t responding to the treatment. Immunotherapy uses the body’s immune system to prevent, control and eliminate cancer. The study is published in Cancer Immunology Research, a journal of the American Association for Cancer … Read more

Arc Institute Emerges After Two Years Of Development

Arc Institute Emerges After Two Years Of Development

Arc Institute is a nonprofit research organization headquartered in Palo Alto, California. Arc is an independent institute that operates in collaboration with Stanford University, the University of California, Berkeley, and the University of California, San Francisco. According to Arc, biomedical innovation in areas such as mRNA technology, gene editing, and cell therapies suggest that historic … Read more

Mapping The Protein Machinery of Cancer Cells

Mapping The Protein Machinery of Cancer Cells

Proteins are often called the workhorses of cells, the machinery that makes cells go. They act as key players in the many chemical reactions constantly occurring in cells, collect cellular garbage, provide structure, repair damaged DNA, and much more. But individual proteins rarely act on their own. Instead, like molecular LEGO bricks, they join together … Read more

Strand Therapeutics Wins NIH CAR-T Cell Immunotherapy Contract

Strand Therapeutics Wins NIH CAR-T Cell Immunotherapy Contract

Strand Therapeutics, a privately held biotech company developing next-generation, programmable mRNA therapeutics beyond vaccines, announced last week that the company was awarded a Phase I Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to develop an off-the-shelf chimeric antigen receptor T cell (CAR-T) immunotherapy … Read more